These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 21480251)

  • 21. Progression-specific genes identified by expression profiling of matched ductal carcinomas in situ and invasive breast tumors, combining laser capture microdissection and oligonucleotide microarray analysis.
    Schuetz CS; Bonin M; Clare SE; Nieselt K; Sotlar K; Walter M; Fehm T; Solomayer E; Riess O; Wallwiener D; Kurek R; Neubauer HJ
    Cancer Res; 2006 May; 66(10):5278-86. PubMed ID: 16707453
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of gene expression profile in colon cancer using the Cancer Genome Anatomy Project and RNA interference.
    Huang ZG; Ran ZH; Lu W; Xiao SD
    Chin J Dig Dis; 2006; 7(2):97-102. PubMed ID: 16643337
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gene expression profiles and molecular markers to predict recurrence of Dukes' B colon cancer.
    Wang Y; Jatkoe T; Zhang Y; Mutch MG; Talantov D; Jiang J; McLeod HL; Atkins D
    J Clin Oncol; 2004 May; 22(9):1564-71. PubMed ID: 15051756
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genomic analysis: toward a new approach in breast cancer management.
    Cavallaro S; Paratore S; de Snoo F; Salomone E; Villari L; Buscarino C; Ferraù F; Banna G; Furci M; Strazzanti A; Cunsolo R; Pezzino S; Gangi S; Basile F
    Crit Rev Oncol Hematol; 2012 Mar; 81(3):207-23. PubMed ID: 21511492
    [TBL] [Abstract][Full Text] [Related]  

  • 25. "Stemness" genomics law governs clinical behavior of human cancer: implications for decision making in disease management.
    Glinsky GV
    J Clin Oncol; 2008 Jun; 26(17):2846-53. PubMed ID: 18539963
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression array technology in the diagnosis and treatment of breast cancer.
    Jeffrey SS; Fero MJ; Børresen-Dale AL; Botstein D
    Mol Interv; 2002 Apr; 2(2):101-9. PubMed ID: 14993355
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hunting for robust gene signature from cancer profiling data: sources of variability, different interpretations, and recent methodological developments.
    Xu JZ; Wong CW
    Cancer Lett; 2010 Oct; 296(1):9-16. PubMed ID: 20579805
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genomic profile of endometrial tumors depends on morphological subtype, not on tamoxifen exposure.
    Fles R; Hoogendoorn WE; Platteel I; Scheerman CE; de Leeuw-Mantel G; Mourits MJ; Hollema H; van Leeuwen FE; van Boven HH; Nederlof PM
    Genes Chromosomes Cancer; 2010 Aug; 49(8):699-710. PubMed ID: 20544844
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biomarkers correlate with colon cancer and risks: a preliminary study.
    Lu S; Chiu YS; Smith AP; Moore D; Lee NM
    Dis Colon Rectum; 2009 Apr; 52(4):715-24. PubMed ID: 19404080
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Application of cDNA microarrays to generate a molecular taxonomy capable of distinguishing between colon cancer and normal colon.
    Zou TT; Selaru FM; Xu Y; Shustova V; Yin J; Mori Y; Shibata D; Sato F; Wang S; Olaru A; Deacu E; Liu TC; Abraham JM; Meltzer SJ
    Oncogene; 2002 Jul; 21(31):4855-62. PubMed ID: 12101425
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular classification of breast cancer: limitations and potential.
    Pusztai L; Mazouni C; Anderson K; Wu Y; Symmans WF
    Oncologist; 2006 Sep; 11(8):868-77. PubMed ID: 16951390
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Limits of predictive models using microarray data for breast cancer clinical treatment outcome.
    Reid JF; Lusa L; De Cecco L; Coradini D; Veneroni S; Daidone MG; Gariboldi M; Pierotti MA
    J Natl Cancer Inst; 2005 Jun; 97(12):927-30. PubMed ID: 15956654
    [TBL] [Abstract][Full Text] [Related]  

  • 33. cDNA microarray analysis of inflammatory breast cancer signatures.
    Laere SJ; Vermeulen PB; Dirix LY
    Methods Mol Biol; 2009; 512():71-98. PubMed ID: 19347274
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transcriptomic signatures in breast cancer.
    Fu J; Jeffrey SS
    Mol Biosyst; 2007 Jul; 3(7):466-72. PubMed ID: 17579771
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nuclear factor-kappaB signature of inflammatory breast cancer by cDNA microarray validated by quantitative real-time reverse transcription-PCR, immunohistochemistry, and nuclear factor-kappaB DNA-binding.
    Van Laere SJ; Van der Auwera I; Van den Eynden GG; Elst HJ; Weyler J; Harris AL; van Dam P; Van Marck EA; Vermeulen PB; Dirix LY
    Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3249-56. PubMed ID: 16740744
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Has the time arrived for gene expression use at the bedside?].
    D'Hondt V; Piccart M; Sotiriou C
    Bull Cancer; 2008 Mar; 95(3):336-43. PubMed ID: 18390414
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Breast cancer special types: why bother?
    Reis-Filho JS; Lakhani SR
    J Pathol; 2008 Dec; 216(4):394-8. PubMed ID: 18798222
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular profiling and risk stratification of adenocarcinoma of the colon.
    Mutch MG
    J Surg Oncol; 2007 Dec; 96(8):693-703. PubMed ID: 18081153
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Gene expression profiling using cDNA arrays and prognosis of breast cancer].
    Bertucci F; Nasser V; Houlgatte R; Birnbaum D
    Bull Cancer; 2002 Jun; 89(6):571-4. PubMed ID: 12135856
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Personalized management of patients with solid cancers: moving from patient characteristics to tumor biology.
    Awada A; Vandone AM; Aftimos P
    Curr Opin Oncol; 2012 May; 24(3):297-304. PubMed ID: 22410457
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.